MICHAEL K. CASE, MD

LA CROSSE, WI

Research Active
Otolaryngology - Otolaryngology/Facial Plastic Surgery NPI registered 21+ years 50 publications 2019 – 2026 NPI: 1497750459
MiceMice, Inbred C57BLDiabetes Mellitus, Type 2Blood GlucoseCOVID-19BrainPandemicsGlycated HemoglobinParkinson DiseaseHypoglycemic AgentsDrug Administration ScheduleAortic DissectionSubthalamic NucleusDeep Brain StimulationCommunication Devices for People with Disabilities

Practice Location

1836 SOUTH AVE
LA CROSSE, WI 54601-5429

Phone: (608) 782-7300

What does MICHAEL CASE research?

Dr. Case studies several important medical conditions, primarily focusing on type 2 diabetes, anxiety-related behaviors, and neurological disorders such as Parkinson's disease. One of his key areas of research involves a new insulin called efsitora alfa, which is administered once a week to improve blood sugar control in individuals with type 2 diabetes. He also examines the use of advanced techniques like deep brain stimulation to enhance treatment outcomes for patients with Parkinson’s disease, focusing on tailoring therapies to individual brain signals. Additionally, Dr. Case investigates the relationship between mitochondrial function and anxiety, aiming to understand the biological underpinnings of anxiety disorders.

Key findings

  • Efsitora reduced blood sugar levels from 8.21% to 6.97% over one year, and had a slightly better control rate compared to degludec (64.3% vs. 61.2%).
  • Patients using weekly insulin efsitora reported lower treatment burden and improved satisfaction compared to those on daily insulin.
  • Adaptive deep brain stimulation detected strong brain signal activity in 84.8% of patients while on medication, indicating its effectiveness in tailoring treatment.
  • Non-Invasive Venous waveform Analysis showed the ability to detect as little as 200 mL of blood loss, leading to quicker treatment responses.
  • A study among older adults with elevated amyloid found that 32.8% experienced brain changes related to amyloid, providing valuable safety data for at-risk populations.

Frequently asked questions

Does Dr. Case study type 2 diabetes?
Yes, Dr. Case focuses on developing treatments for type 2 diabetes, including a new insulin that can be administered once a week.
What treatments has Dr. Case researched for Parkinson's disease?
He has researched deep brain stimulation techniques and adaptive stimulation strategies to improve symptom management in Parkinson's disease patients.
Is Dr. Case's work relevant to anxiety disorders?
Yes, he studies the biological links between mitochondrial function and anxiety behaviors, which could inform future treatments for anxiety disorders.
How does Dr. Case's research help people with disabilities?
He investigates AI applications to improve communication methods for individuals with visual and motor disabilities, enhancing their ability to express themselves.
What findings does Dr. Case have regarding older adults at risk for Alzheimer's disease?
His research demonstrates that a significant portion of older adults with elevated amyloid experienced brain changes over time, contributing to safety discussions in at-risk populations.

Publications in plain English

Consideration of artificial intelligence applications for interpreting communicative movements by individuals with visual and/or motor disabilities.

2026

Augmentative and alternative communication (Baltimore, Md. : 1985)

Wilkinson KM, Sowers DJ, Elko LR, Case M, Redmon S +3 more

Plain English
This study looked at how artificial intelligence could help people with visual and motor disabilities communicate by interpreting their gestures into speech. The researchers created a prototype app that successfully learned specific gestures while ignoring accidental movements, showing that it can work regardless of how the person is positioned. This approach could make communication devices easier to use, ensuring that more people can effectively express themselves. Who this helps: This benefits individuals with visual and motor disabilities who need better ways to communicate.

PubMed

Anxiety-Associated Behaviors Following Ablation offrom Cortical Excitatory Neurons.

2026

eNeuro

Myers AK, Sakheim M, Rivell C, Fengler C, Festa LK +13 more

Plain English
Researchers studied how changes in a specific protein (MIRO1) that affects mitochondria (the energy centers of cells) in the brain relate to anxiety-related behaviors in mice. They discovered that when this protein was removed in certain brain cells, the mice showed less brain weight and abnormal activity patterns, leading to anxiety-like behaviors, such as avoiding confined spaces. These findings matter because they connect mitochondrial function to anxiety and other mental health issues, suggesting that targeting this pathway may help in treating related disorders. Who this helps: This helps patients with anxiety disorders and their doctors.

PubMed

Evaluation of Overall Health State, Treatment Burden, and Satisfaction with Insulin Efsitora Alfa (Efsitora) vs. Daily Comparator in Adults with Type 2 Diabetes in the QWINT Clinical Trial Program.

2026

Diabetes therapy : research, treatment and education of diabetes and related disorders

Miller E, Davidson MB, Bajaj HS, Rosenstock J, Philis-Tsimikis A +6 more

Plain English
This study compared a new insulin called efsitora, which is taken once a week, to daily insulins like glargine and degludec for adults with Type 2 diabetes. The results showed that efsitora provided similar effectiveness and safety, but participants reported significantly better experiences, such as less treatment burden and improved satisfaction with their diabetes management. Overall, those using efsitora felt healthier and had a better quality of life compared to those taking daily insulin. Who this helps: This helps adults with Type 2 diabetes seeking easier and more satisfying treatment options.

PubMed

Characterisation of steady-state pharmacokinetics and glucodynamics of once-weekly insulin efsitora alfa in individuals with type 2 diabetes.

2026

Diabetes, obesity & metabolism

Leohr J, Klein O, Heise T, Zijlstra E, Bue-Valleskey JM +7 more

Plain English
This study looked at how well a new type of insulin, called efsitora alfa, works over a week for people with type 2 diabetes. Researchers found that after using efsitora once a week, blood sugar levels were effectively lowered and stayed stable, with a small peak difference during the dosing period. This matters because it shows that efsitora can provide consistent control of blood sugar with just one dose a week, offering a potentially easier treatment option for diabetes management. Who this helps: Patients with type 2 diabetes seeking easier insulin options.

PubMed

A generalizable and targeted molecular biopsy approach for in situ cryogenic electron tomography of vitreous brain tissue.

2025

Cell reports methods

Glynn C, Smith JLR, Case M, Csöndör R, Katsini A +4 more

Plain English
This study looked at a new method for examining the detailed structure of brain tissue, specifically in the hippocampus region of mice. Researchers found a complex organization of important molecules in specific areas of the hippocampus, which helps create a detailed map of its structure. This approach allows for better investigation of brain tissues, which is important for understanding various brain functions and conditions. Who this helps: Patients with neurological conditions and researchers studying brain health.

PubMed

A prospective, observational study of non-invasive venous waveform analysis (NIVA) for the detection of acute low volume blood loss in humans.

2025

Journal of clinical anesthesia

Alvis BD, Wervey D, Pein R, Wise E, Sobey J +8 more

Plain English
This study looked at a new method called Non-Invasive Venous waveform Analysis (NIVA) to see if it can accurately detect small amounts of blood loss in people. Researchers found that NIVA could detect a loss of just 200 mL (about 3-4% of total blood volume) during blood donations, achieving a significant decrease in a specific measurement called the IntraVAscular Number (IVAN). This ability to catch low-volume bleeding early is important because it can lead to quicker treatment and better outcomes for patients in emergencies. Who this helps: This research benefits patients who might be experiencing low-volume blood loss.

PubMed

Protocol for a randomized trial of self-management support for people with chronic obstructive pulmonary disease using lay health coaches.

2025

Contemporary clinical trials

Agrawal N, Case M, Lindenauer PK, McDermott D, Diaz KM +3 more

Plain English
This study examines a program called SAMBA, which helps adults with chronic obstructive pulmonary disease (COPD) manage their condition by using health coaches. Involving 300 participants, the program focuses on addressing personal challenges related to medication use, exercise, and early treatment of exacerbations over six months. The goal is to improve medication adherence, exercise capacity, symptoms, and overall quality of life, while reducing hospital visits. Who this helps: This research benefits patients with COPD by providing tools and support for better self-management of their condition.

PubMed

Unipolar recordings of beta power inform initial programming of the subthalamic nucleus in Parkinson's disease.

2025

Parkinsonism & related disorders

Thompson JA, Radcliffe EM, Ojemann S, Kramer DR, David-Gerecht P +6 more

Plain English
This study looked at how using a specific technique called unipolar recordings of beta power can help doctors better program deep brain stimulation (DBS) for patients with Parkinson's disease. The researchers found that while both the unipolar method and the traditional method were equally effective in improving patients' symptoms, unipolar recordings made the process of selecting stimulation contacts much faster—showing a significant time efficiency. This is important because faster and more effective programming means patients could experience symptom relief sooner. Who this helps: This helps patients with Parkinson's disease by potentially speeding up their treatment process.

PubMed

Pilot Study to Investigate the Use of In-Clinic Sensing to Identify Optimal Stimulation Parameters for Deep Brain Stimulation Therapy in Parkinson's Disease.

2024

Neuromodulation : journal of the International Neuromodulation Society

Lewis S, Radcliffe E, Ojemann S, Kramer DR, Hirt L +5 more

Plain English
This study looked at a new way to optimize deep brain stimulation (DBS) settings for patients with Parkinson's disease by using advanced sensing technology. Researchers tested this method on five patients and found that the optimal stimulation settings based on this technology matched existing clinical methods in 5 out of 9 cases and were preferred by both doctors and patients in most instances. This matter because it could make DBS programming quicker and more effective, improving patient comfort and outcomes. Who this helps: Patients with Parkinson's disease who receive deep brain stimulation therapy.

PubMed

A retrospective chart review of the patient population accessing augmentative & alternative communication at an urban assistive technology center.

2024

Assistive technology : the official journal of RESNA

Bean A, Zezinka J, DiGiovine C, Sonntag AM, Case M

Plain English
This study looked at 53 people who went to an assistive technology center in the Midwest for evaluations of alternative and augmentative communication (AAC) devices, which help those with communication difficulties. The researchers found that most participants had progressive diseases and prioritized ease of use and effectiveness in these devices. This is important because understanding what patients value can help improve AAC services and make sure that everyone gets the help they need. Who this helps: Patients with communication challenges.

PubMed

Survival Outcomes of Medullary Thyroid Cancer With and Without Amyloid Deposition.

2024

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Toraih E, Hussein M, Anker A, Baah S, Pinion D +6 more

Plain English
The researchers studied medullary thyroid cancer (MTC) to see how the presence of amyloid deposits in the tumors affects survival outcomes. They analyzed data from 2,526 MTC patients and found that while those with amyloid deposits had lower initial tumor stages (28% at advanced stages compared to 85% for those without amyloid), they also showed a trend toward worse cancer-specific survival, with a hazard ratio of 1.31. Importantly, starting treatment more than a month after diagnosis led to worse overall survival rates, indicating that earlier intervention is critical for better outcomes. Who this helps: This helps patients diagnosed with medullary thyroid cancer and their doctors in understanding the importance of timely treatment.

PubMed

Adult and Pediatric Porcine Model of Acute Volume Overload.

2024

Journal of visualized experiments : JoVE

Alvis BD, Sobey JH, Vaughn L, Jelly C, Wervey D +4 more

Plain English
This study looked at how adult pigs and piglets respond to a sudden increase in blood volume, which can happen in medical situations. The researchers found that in adult pigs, several heart and blood pressure measurements changed significantly with the overload, while in piglets, only one particular measurement (pulmonary capillary wedge pressure) showed a similar significant change. Understanding these dynamics is crucial for developing better treatments and monitoring techniques for both adults and children who experience acute volume overload. Who this helps: This benefits doctors and healthcare providers treating patients with heart and blood pressure issues.

PubMed

Machine learning to predict continuous protein properties from binary cell sorting data and map unseen sequence space.

2024

Proceedings of the National Academy of Sciences of the United States of America

Case M, Smith M, Vinh J, Thurber G

Plain English
Researchers studied how to better predict the characteristics of proteins using data from simpler experiments that sort cells. They found that their method could accurately predict protein properties using data that was less precise, achieving results close to those obtained with more complex and costly techniques. This matters because it allows scientists to discover and create improved proteins more efficiently, which can advance various medical and industrial applications. Who this helps: This benefits researchers and engineers working on protein development.

PubMed

A Porcine Model of Acute Respiratory Failure with a Continuous Infusion of Oleic Acid.

2024

Journal of visualized experiments : JoVE

Alvis BD, Brophy C, Cheung-Flynn J, Case M, Hocking K

Plain English
This study focused on creating a realistic model of acute respiratory failure using Yorkshire pigs by continuously administering oleic acid, mimicking severe lung issues. The researchers found that after about 60 minutes of oleic acid infusion, the pigs showed significantly reduced oxygen levels in their blood, and their lungs displayed damage typical of acute respiratory distress. This research is important because it helps improve the understanding of respiratory failure, which can lead to better treatments and interventions for affected patients. Who this helps: This benefits patients experiencing acute respiratory failure and their doctors.

PubMed

Safety Profile of a Cognitively Unimpaired Older Population with Elevated Cerebral Amyloid in a 4.5-Year Clinical Trial.

2024

The journal of prevention of Alzheimer's disease

Yaari R, Holdridge KC, Mancini M, Rafii MS, Case M +4 more

Plain English
This study looked at the safety of a group of older adults who did not show signs of dementia but had high levels of amyloid in their brains, which is linked to Alzheimer's disease. Over 4.5 years, 591 participants were monitored for health issues while receiving a placebo treatment. They found that 32.8% of participants experienced brain changes related to amyloid, and the most common serious health events included pneumonia and atrial fibrillation, with incidence rates of 0.4 per 100 person-years. Who this helps: This information is valuable for researchers and doctors studying Alzheimer's disease, as it helps them understand safety concerns in patients at risk for the disease.

PubMed

Comparison of beta peak detection algorithms for data-driven deep brain stimulation programming strategies in Parkinson's disease.

2024

NPJ Parkinson's disease

Baker SK, Radcliffe EM, Kramer DR, Ojemann S, Case M +6 more

Plain English
This study looked at different algorithms that help detect brain signals called beta peaks, which are important for adjusting deep brain stimulation (DBS) treatment in patients with Parkinson's disease. The researchers found that the best algorithms matched expert opinions on identifying these signals and accurately predicted treatment parameters during follow-ups. This is important because it can help make DBS programming more objective, potentially leading to better-tailored treatments for patients. Who this helps: Patients with Parkinson's disease who receive deep brain stimulation therapy.

PubMed

Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment.

2024

The New England journal of medicine

Wysham C, Bajaj HS, Del Prato S, Franco DR, Kiyosue A +6 more

Plain English
This study compared two types of insulin—efsitora and degludec—in adults with type 2 diabetes who had never used insulin before. Over a year, both insulins effectively lowered blood sugar levels; efsitora reduced levels from about 8.21% to 6.97%, while degludec went from 8.24% to 7.05%. Efsitora performed just as well as degludec, reducing blood sugar without causing severe low blood sugar episodes and allowing patients to maintain their blood sugar levels within target range slightly better (64.3% of the time compared to 61.2% for degludec). Who this helps: This research benefits patients with type 2 diabetes who need insulin for better blood sugar control.

PubMed

Sensing data and methodology from the Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) clinical trial.

2024

NPJ Parkinson's disease

Stanslaski S, Summers RLS, Tonder L, Tan Y, Case M +16 more

Plain English
This study looked at a new type of brain stimulation called Adaptive deep brain stimulation (aDBS) in patients with Parkinson's disease. Researchers found that 84.8% of patients detected strong brain signal activity while on medication and 92% while off medication. This is important because it shows that aDBS can consistently identify brain signals, which could lead to more personalized and effective treatments for Parkinson's disease. Who this helps: This helps patients with Parkinson's disease seeking better treatment options.

PubMed

East Victoria long term hydrodynamic modelling: Dataset and methodology.

2024

Data in brief

Greer D, McIntosh R, Case M, McLean DL, Treml EA +1 more

Plain English
This study created a detailed computer model to simulate water movement in Bass Strait, which is located in south-eastern Australia. The model accurately reflects how tides, wind, and temperature affect the water flow and shows consistent results when compared to real-world measurements. This research is important because it helps us understand the behavior of ocean currents in this region, which can impact marine life and navigation. Who this helps: This benefits marine researchers, environmentalists, and local fisheries.

PubMed

The Impact of Mentoring on Academic Career Success in Surgical Subspecialties: A Systematic Review.

2024

Journal of surgical education

Case M, Herrera M, Rumps MV, Mulcahey MK

Plain English
This study looked at how mentoring affects the career success of women in surgical specialties, revealing that 60% of the research highlighted the positive impact of mentorship on their careers. It found that having female mentors is particularly important, with many women surgeons preferring to have mentors of the same gender, yet there's a notable lack of female mentors available. Improving access to effective mentoring could lead to better career advancement for women in surgery, promoting gender equality in these fields. Who this helps: This benefits female surgical residents and fellows seeking to advance their careers.

PubMed

The Impact of Burr Hole Device and Lead Design on Deep Brain Stimulation Lead Stability in Benchtop and Ovine Models.

2023

Neuromodulation : journal of the International Neuromodulation Society

Baxter W, Salb K, Case M, Billstrom T

Plain English
This study looked at how the design of deep brain stimulation (DBS) devices affects the stability of the leads that send electrical signals to the brain. Researchers found that a new DBS lead system stayed in place 55% better than an older system, which is important for ensuring effective therapy. Additionally, the new design needed much more force to be rotated, indicating it is more stable overall. Who this helps: This benefits patients with neurological conditions who rely on DBS for effective treatment.

PubMed

Telehealth as a Tool to Improve Access and Reduce No-Show Rates in a Large Safety-Net Population in the USA.

2023

Journal of urban health : bulletin of the New York Academy of Medicine

Sumarsono A, Case M, Kassa S, Moran B

Plain English
Researchers studied how telehealth appointments affected the number of missed visits among low-income patients at Parkland Health from March 2020 to June 2022. They found that telehealth visits reduced the likelihood of missed appointments by 29%. This is especially important for patients of Black race and those living in areas with high social vulnerability, highlighting telehealth's role in improving access to care for disadvantaged groups. Who this helps: Patients in low-income and underserved communities.

PubMed

Rapid Evaluation of Staple Placement in Stabilized α Helices Using Bacterial Surface Display.

2023

ACS chemical biology

Case M, Navaratna T, Vinh J, Thurber G

Plain English
This study looked at a method called SPEED to improve the design of specially crafted peptides, which are small pieces of proteins. Researchers found that by changing certain parts of these peptides, they could create new compounds that effectively target proteins involved in cancer, specifically the mdm2-p53 interaction and the Bcl-2 family, with some showing effectiveness in the nanomolar range. This matters because it opens the door to new treatments for diseases caused by difficult-to-reach proteins inside cells. Who this helps: This helps patients with cancer by potentially leading to more effective therapies.

PubMed

Clinical Practices Surrounding the Prescription of Home Oxygen in Patients With COPD and Desaturation.

2023

Chronic obstructive pulmonary diseases (Miami, Fla.)

Zaeh SE, Case M, Au DH, DaSilva M, Deitemeyer K +7 more

Plain English
The study looked at how doctors and nurses decide to prescribe home oxygen to patients with chronic obstructive pulmonary disease (COPD), especially those who experience low oxygen levels during activity. Researchers interviewed 18 healthcare providers and found that most of them discuss the benefits and risks with patients, but they don’t use any specific tools to guide these conversations. This is important because having better support for these discussions could lead to more personalized care and improve patients' health decisions. Who this helps: This research benefits patients with COPD and the healthcare providers who care for them.

PubMed

Trial of Solanezumab in Preclinical Alzheimer's Disease.

2023

The New England journal of medicine

Sperling RA, Donohue MC, Raman R, Rafii MS, Johnson K +11 more

Plain English
Researchers studied a medication called solanezumab to see if it could slow mental decline in older adults (ages 65 to 85) with early signs of Alzheimer's disease, specifically those with elevated levels of amyloid protein in the brain. After nearly five years, they found that participants taking solanezumab showed a negligible difference in cognitive scores compared to those taking a placebo, with scores dropping by about 1.43 points in the treatment group and 1.13 points in the placebo group. This matters because it indicates that solanezumab does not effectively slow cognitive decline in the early stages of Alzheimer's, which is important for developing future treatments. Who this helps: This research helps patients and their families by providing clarity on the effectiveness of solanezumab for early Alzheimer's.

PubMed

Mesophotic benthic communities associated with a submerged palaeoshoreline in Western Australia.

2023

PloS one

Wakeford M, Puotinen M, Nicholas W, Colquhoun J, Vaughan BI +6 more

Plain English
This study looked at a submerged ancient coastline in Western Australia to understand its underwater ecosystems better. Researchers found that about 98% of the seabed was made up of soft sediments like mud and sand, with very little life visible on the seafloor; total plant and animal cover was only between 0.02% and 1.07%. The results suggest that the ancient coastline may be mostly buried, which means it does not provide the unique habitats it once did, highlighting the need for further research to understand these underwater environments. Who this helps: This research helps conservationists and policymakers by providing essential information for marine protection and management.

PubMed

Evaluation of common clinical and hemodynamic parameters to pulmonary capillary wedge pressures in patients undergoing right heart catheterization.

2023

Medical research archives

Hocking KM, Huston J, Schmeckpeper J, Polcz M, Case M +6 more

Plain English
This study looked at how common clinical signs and measurements relate to a specific heart pressure measurement called pulmonary capillary wedge pressure (PCWP) in patients with heart failure. Researchers analyzed data from 538 patients and found that ten out of 17 clinical and hemodynamic factors significantly correlated with PCWP, with pulmonary artery diastolic pressure showing the strongest link, followed by right atrial pressure and pulmonary artery systolic pressure. Understanding these relationships helps doctors assess heart failure more accurately and improve patient care. Who this helps: This benefits heart failure patients and their doctors.

PubMed

Hyperactive CREB subpopulations increase during therapy in pediatric B-lineage acute lymphoblastic leukemia.

2023

Haematologica

Masic D, Fee K, Bell H, Case M, Witherington G +7 more

Plain English
This study looked at pediatric patients with B-lineage acute lymphoblastic leukemia (ALL) to understand why some cancer cells persist during chemotherapy. Researchers found that a specific protein, pCREB, was active in many of the cancer cells both at the start of treatment and during the therapy, indicating that these cells might be better at surviving the treatment. They identified a growing subgroup of cells with this protein that could be linked to treatment resistance, suggesting that targeting this signaling pathway could help improve outcomes for patients at high risk of relapse. Who this helps: Patients with pediatric B-ALL and healthcare providers looking for better treatment options.

PubMed

Noninvasive Venous Waveform Analysis Correlates With Pulmonary Capillary Wedge Pressure and Predicts 30-Day Admission in Patients With Heart Failure Undergoing Right Heart Catheterization.

2022

Journal of cardiac failure

Alvis B, Huston J, Schmeckpeper J, Polcz M, Case M +8 more

Plain English
This study looked at a new technology called noninvasive venous waveform analysis (NIVA) to see how well it predicts whether heart failure patients will need to be hospitalized again within 30 days after their discharge. The researchers found that a NIVA score over 18 was linked to a 91% chance of predicting readmission, with a strong correlation to an established measurement called pulmonary capillary wedge pressure (PCWP). This is important because it offers a way to monitor heart failure patients without invasive procedures, potentially helping to prevent unnecessary hospital stays. Who this helps: Patients with heart failure.

PubMed

When opinion masquerades as fact.

2022

Acta paediatrica (Oslo, Norway : 1992)

Donaruma M, Desai N, Shanghvi D, Case M, Choudhary A +1 more

PubMed

A Review of the Effectiveness of Audio-Only Telemedicine for Chronic Disease Management.

2022

Telemedicine journal and e-health : the official journal of the American Telemedicine Association

Moran B, Frazier T, Brown LS, Case M, Polineni S +1 more

Plain English
This study looked at how effective audio-only telemedicine is for managing chronic diseases like kidney disease, high blood pressure, and diabetes compared to in-person visits and hybrid care models during the pandemic. Researchers analyzed data from 52,720 patients and found that audio-only telemedicine was just as effective as in-person visits for controlling these diseases, with 48,335 patients included in the comparison group. This matters because it shows that patients can successfully manage their chronic health conditions through phone consultations, making healthcare more accessible. Who this helps: Patients with chronic diseases who may prefer or need remote care options.

PubMed

A mixed method approach to understanding the impact of COVID-19 on patients with or at risk for aortic dissection.

2022

Seminars in vascular surgery

Lee JR, Segal C, Howitt J, Lawrence SO, Grima J +12 more

Plain English
This study looked at how the COVID-19 pandemic affected people with or at risk for aortic dissection, a serious condition involving a tear in the aorta. Between March and October 2020, researchers found that these patients faced confusion about their health risks related to COVID-19 and experienced major disruptions in their medical care. However, the shift to telehealth helped some patients access specialized care more easily, highlighting both challenges and new opportunities during the pandemic. Who this helps: This helps patients with aortic dissection and healthcare providers.

PubMed

Lived experiences of people with or at risk for aortic dissection: A qualitative assessment.

2022

Seminars in vascular surgery

Lee JR, Segal C, Howitt J, Case M, Cotter N +5 more

Plain English
This study looked at the experiences of people who have had or are at risk for aortic dissection, a serious condition where the aorta tears. Researchers found that patients often first face a lot of stress when diagnosed, struggle to get the support and information they need, feel overwhelmed by managing their own care, and experience mental health challenges that aren’t addressed. These insights are important because they highlight the need for better support systems and improved communication in healthcare to help these individuals live healthier lives. Who this helps: Patients with aortic dissection and their healthcare providers.

PubMed

The Aortic Dissection Collaborative: Methods for building capacity for patient-centered outcomes research in the aortic dissection community.

2022

Seminars in vascular surgery

Lee JR, Lawrence SO, Soto M, Case M, Cotter N +6 more

Plain English
This study focused on improving research related to aortic dissection by understanding the needs and concerns of patients and their families. Researchers gathered feedback through surveys and interviews with people affected by aortic dissection, which helped identify seven key topics for future research. This work is important because it ensures that upcoming studies will address what truly matters to patients, leading to better treatment decisions and outcomes. Who this helps: This benefits patients with aortic dissection and their families, as well as their doctors.

PubMed

Methylphenidate effects on a clinically informative oscillatory signal within the subthalamic nucleus in Parkinson's disease during deep brain stimulation programming.

2022

Brain stimulation

Kern D, Korsmo M, Baumgartner AJ, Kramer D, Ojemann S +4 more

PubMed

Comparison of clinical symptoms and bioimpedance to pulmonary capillary wedge pressure in heart failure.

2022

American heart journal plus : cardiology research and practice

Polcz M, Huston J, Breed M, Case M, Leisy P +7 more

Plain English
This study looked at how well traditional health signs, like swelling and shortness of breath, can predict heart failure and hospital stays, comparing them with new technology using bioimpedance measurements. Researchers found that neither the clinical symptoms nor the bioimpedance readings reliably predicted heart problems, with no significant connections to a specific heart pressure measurement (pulmonary capillary wedge pressure). This matters because it highlights the limitations of current methods for monitoring heart failure, suggesting a need for better ways to assess patients. Who this helps: Patients with heart failure and their doctors.

PubMed

Integrated Alzheimer's Disease Rating Scale: Clinically meaningful change estimates.

2022

Alzheimer's & dementia (New York, N. Y.)

Wessels AM, Rentz DM, Case M, Lauzon S, Sims JR

Plain English
This study focused on the Integrated Alzheimer's Disease Rating Scale (iADRS), which helps track the progress of Alzheimer's in patients. Researchers found that a change of 5 points on this scale is considered significant for people with mild cognitive impairment, and a change of 9 points is critical for those with mild dementia. These findings are important because they provide clear benchmarks that can improve how clinical trials measure the effectiveness of treatments for Alzheimer's disease. Who this helps: This helps patients with Alzheimer's and their doctors by providing clearer guidelines for assessing treatment effects.

PubMed

Exposures to low-levels of fine particulate matter are associated with acute changes in heart rate variability, cardiac repolarization, and circulating blood lipids in coronary artery disease patients.

2022

Environmental research

Mirowsky JE, Carraway MS, Dhingra R, Tong H, Neas L +8 more

Plain English
The study looked at how exposure to low levels of air pollution, specifically fine particulate matter (PM) and ozone, affects heart health in men with stable coronary artery disease. Researchers found that for every small increase in PM, there were significant drops in heart rate variability (up to 8.1%) and changes in cholesterol levels, indicating a potential increase in cardiovascular risk, even at pollution levels considered safe by government standards. This matters because it highlights that air pollution can harm heart health in sensitive individuals, which may lead to more serious health issues over time. Who this helps: This helps patients with coronary artery disease and their doctors by highlighting the risks of air pollution.

PubMed

Magnetic resonance imaging measures of brain volumes across the EXPEDITION trials in mild and moderate Alzheimer's disease dementia.

2022

Alzheimer's & dementia (New York, N. Y.)

Svaldi DO, Higgins IA, Holdridge KC, Yaari R, Case M +4 more

Plain English
The study looked at the effects of a drug called solanezumab on brain volume in patients with mild to moderate Alzheimer's disease over a span of 80 weeks. Researchers found that there was no significant change in brain size or the volume of brain ventricles in patients who took solanezumab compared to those who took a placebo, which included a total of 2,933 participants. This matters because it indicates that low-dose solanezumab does not impact brain volume in this patient group, suggesting the need for further investigation into higher doses or alternative therapies. Who this helps: This helps researchers and healthcare providers seeking effective treatments for Alzheimer's disease.

PubMed

A quantitative comparison of towed-camera and diver-camera transects for monitoring coral reefs.

2021

PeerJ

Cresswell AK, Ryan NM, Heyward AJ, Smith ANH, Colquhoun J +7 more

Plain English
This study compared two methods for monitoring coral reefs: diver cameras and towed cameras. Researchers found that towed cameras were less effective at capturing detailed images of the reef, especially in complex habitats; the differences in percent cover for corals varied depending on the reef's structure and increased with slope. The study highlighted that towed cameras could be improved by changing how they collect data, which matters because efficient monitoring is crucial for preserving coral reefs. Who this helps: This helps scientists and environmental managers who monitor coral health.

PubMed

Translational PK/PD and model-informed development of JNJ-67842125, a Freversal agent for JNJ-64179375, a long-acting thrombin inhibitor.

2021

British journal of pharmacology

Ayyar VS, Jaiprasart P, Geist B, Huang Devine Z, Case M +4 more

Plain English
This study looked at how well three different agents can reverse the blood-thinning effects of a medication called JNJ-64179375, which is a long-acting treatment for blood clots. Researchers tested these agents in monkeys and found that the best one, JNJ-67842125, effectively reduced the anticoagulant effects, which helps restore normal clotting. The study identified that JNJ-64179375 clears from the body at a rate of 2.75 ml per day per kg, while the reversal agents clear much faster, between 1400 and 2400 ml per day per kg. Who this helps: This benefits patients who need quick reversal of blood thinners in emergencies.

PubMed

Commentary on: Dror IE, Melinek J, Arden JL, Kukucka J, Hawkins S, Carter J, et al. Cognitive bias in forensic pathology decisions. J Forensic Sci. https://doi.org/10.1111/1556-4029.14697. Epub 2021 Feb 20.

2021

Journal of forensic sciences

Peterson BL, Arnall M, Avedschmidt S, Beers D, Bell M +81 more

PubMed

Partnerships to Care for Our Patients and Communities During COVID-19.

2021

Journal of the American Board of Family Medicine : JABFM

Viera AJ, Barnett J, Case M, Epling C, Halstater B +10 more

Plain English
This study looked at how academic medical centers, especially family medicine departments, responded to the challenges posed by the COVID-19 pandemic. It found that coordinated efforts, including sharing data and resources, were crucial in addressing patient needs, with the Duke Department of Family Medicine playing a significant role in supporting employee and student health services. This matters because the pandemic highlighted existing social and economic inequalities, and effective partnerships helped improve care for vulnerable communities. Who this helps: This helps patients, healthcare workers, and communities affected by inequalities.

PubMed

Respiratory Non-Invasive Venous Waveform Analysis for Assessment of Respiratory Distress in Coronavirus Disease 2019 Patients: An Observational Study.

2021

Critical care explorations

Alvis B, Vaughn L, Schmeckpeper J, Huston J, Case M +4 more

Plain English
This study looked at how a new method, which analyzes non-invasive venous waveforms, can help identify respiratory distress in COVID-19 patients. Among the 45 patients analyzed, those who needed supplemental oxygen had a significantly higher respiratory index (0.27) compared to healthy individuals (0.06). This new method shows promise in quickly assessing patients and predicting who may need oxygen support during their hospital stay. Who this helps: This helps doctors better identify and manage COVID-19 patients facing respiratory issues.

PubMed

Directed Evolution Using Stabilized Bacterial Peptide Display.

2020

Journal of the American Chemical Society

Navaratna T, Atangcho L, Mahajan M, Subramanian V, Case M +3 more

Plain English
This study focused on creating more effective drug-like peptides that can target difficult diseases by using a new method to evolve and stabilize these peptides. Researchers found several peptides that were stronger and more stable, with one achieving an impressive binding strength of 1.8 nanomolar against a key protein interface involved in cancer. This approach helps speed up the development of potential therapies for hard-to-treat conditions. Who this helps: Patients with cancer and other diseases that are challenging to treat.

PubMed

Effects of Lasmiditan on Cardiovascular Parameters and Pharmacokinetics in Healthy Subjects Receiving Oral Doses of Propranolol.

2020

Clinical pharmacology in drug development

Tsai M, Case M, Ardayfio P, Hochstetler H, Wilbraham D

Plain English
This study looked at how lasmiditan, a medication for treating migraines, affects heart rates and blood pressure when taken with propranolol, a drug often used to prevent migraines. Researchers found that using both drugs together led to a slight drop in heart rate (by about 6.5 beats per minute) and a temporary increase in blood pressure (by about 8.3 mm Hg systolic and 6.4 mm Hg diastolic). This is important because it shows that while there are some cardiovascular effects when they are taken together, both medications can generally be used safely at the same time. Who this helps: This benefits migraine patients who require both lasmiditan for acute treatment and propranolol for prevention.

PubMed

Label-Free Leukemia Monitoring by Computer Vision.

2020

Cytometry. Part A : the journal of the International Society for Analytical Cytology

Doan M, Case M, Masic D, Hennig H, McQuin C +11 more

Plain English
This study looked at a new way to monitor childhood leukemia, specifically acute lymphoblastic leukemia (ALL), using computer vision rather than traditional fluorescent markers. The researchers found that their deep learning technology could accurately identify leukemia cells with over 88% accuracy without requiring special labeling. This method is faster, cheaper, and could easily be adapted for use in doctors' offices, making it easier to track patients’ responses to treatment. Who this helps: This benefits doctors and healthcare providers managing childhood leukemia.

PubMed

Universal masking is an effective strategy to flatten the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) healthcare worker epidemiologic curve.

2020

Infection control and hospital epidemiology

Seidelman JL, Lewis SS, Advani SD, Akinboyo IC, Epling C +8 more

PubMed

Pain Freedom at 2 to 8 Hours With Lasmiditan: A Comparison With Rimegepant and Ubrogepant.

2020

Headache

Doty EG, Krege JH, Pohl G, Case M, Dowsett SA +1 more

PubMed

In Response to: Decoding Readiness: Toward a Ready Military Health Care Force.

2019

Military medicine

Case M, Brown K, Lennon R, Hwang D, Sanchack K

PubMed

Frequent Co-Authors

Colleen Brophy Lexie Vaughn Kyle Hocking John A Thompson Steven Ojemann Bret D Alvis Meghan Breed Jessica Huston Daniel R Kramer

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.